Modeling of Heart Failure with Cyclophosphamide
https://doi.org/10.33647/2713-0428-20-3E-182-186
Abstract
The article presents the results of reproduction of the cyclophosphane model of heart failure. Outbred mice weighing 18–26 g at the onset of the experiment were used. All mice were divided into two groups with 10 animals in each. The first group was injected intraperitoneally with cyclophosphamide at a dose of 15 mg/kg, five times for 21 days (day 1, 5, 10, 15, and 21). The second group was intact animals. EchoCG was performed on the animals twice: baseline before the experiment (point 1) and one week after the last injection (point 2, day 28). The presented experimental model may be used for the study of drug toxicity prevention methods, as well as a model of heart failure with preserved left ventricular ejection fraction.
About the Authors
E. M. Evgenieva
Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Ekaterina M. Evgenieva
197376, Sant Petersburg, Professora Popova Str., 14, lit. A
A. V. Chernomordova
First Saint Petersburg State Medical University named after Academician I.P. Pavlov of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Alexandra V. Chernomordova
197022, Saint Petersburg, L’va Tolstogo Str., 6–8
S. V. Okovitiy
Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Sergey V. Okovitiy, Dr. Sci. (Med.), Prof.
197376, Sant Petersburg, Professora Popova Str., 14, lit. A
A. N. Kulikov
First Saint Petersburg State Medical University named after Academician I.P. Pavlov of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Alexander N. Kulikov, Dr. Sci. (Med.), Prof.
197022, Saint Petersburg, L’va Tolstogo Str., 6–8
References
1. Larina V.N., Kokorin V.A., Larin V.G., Lunev V.I., Suvorova N.A., Skiba I.K., Shcherbina E.S. Dekompensatsiya khronicheskoy serdechnoy nedostatochnosti: novyy vzglyad na problemu v svete obnovlennogo konsensusa ekspertov Evropeyskogo obshchestva kardiologov [Decompensated heart failure: a reconceptualization in the light of updated consensus statement of the European Society of Cardiology]. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology]. 2023;28(12):5581. (In Russian). DOI: 10.15829/1560-4071-2023-5581
2. Attia A.A., Sorour J.M., Mohamed N.A., Mansour T.T., Al-Eisa R.A., El-Shenawy N.S. Biochemical, histological, and ultrastructural studies of the protective role of vitamin E on cyclophosphamide-induced cardiotoxicity in male rats. Biomedicines. 2023;11(2):390. DOI: 10.3390/biomedicines11020390
3. Hassanein E.H.M., Abd El-Ghafar O.A.M., Ahmed M.A., Sayed A.M., Gad-Elrab W.M., Ajarem J.S., Allam A.A., Mahmoud A.M. Edaravone and acetovanillone upregulate Nrf2 and PI3K/Akt/mTOR signaling and prevent cyclophosphamide cardiotoxicity in rats. Drug Des. Devel. Ther. 2020;14:5275–5288. DOI: 10.2147/DDDT.S281854
4. Hopkins H.A., Betsill W.L. Jr., Hobson A.S., Looney W.B. Cyclophosphamide-induced cardiomyopathy in the rat. Cancer Treat. Rep. 1982;66(7): 1521–1527.
5. Iqubal A., Iqubal M.K., Sharma S., Ansari M.A., Najmi A.K., Ali S.M., Ali J., Haque S.E. Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision. Life Sciences. 2019;218:112–131. DOI: 10.1016/j.lfs.2018.12.018
6. Lin C.J., Vader J.M., Slade M., DiPersio J.F., Westervelt P., Romee R. Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation. Cancer. 2017;123(10): 1800–1809. DOI: 10.1002/cncr.30534
7. Liu K., Ren X.-M., You Q.-S., Gu M.-M., Wang F., Wang S., Ma C.-H., Li W.-N., Ye Q. Ameliorative effect of dangguibuxue decoction against cyclophosphamide-induced heart injury in mice. BioMed Research International. 2018;8503109:10. DOI: 10.1155/2018/8503109
Review
For citations:
Evgenieva E.M., Chernomordova A.V., Okovitiy S.V., Kulikov A.N. Modeling of Heart Failure with Cyclophosphamide. Journal Biomed. 2024;20(3E):182-186. (In Russ.) https://doi.org/10.33647/2713-0428-20-3E-182-186
Views:
92
Email this article 
